1.Health-promoting behaviors and related factors among the elderly population in a community in Pudong New Area of Shanghai in 2025
Mengzhen WANG ; Haoran ZHANG ; Yan ZHANG ; Jiaxin LI ; Ruochen LI ; Xingyu LIN ; Shile WANG ; Hao LIU ; Qi ZHAO
Shanghai Journal of Preventive Medicine 2026;38(9):714-719
ObjectiveTo investigate the current status of health-promoting behaviors among elderly residents in a community in Pudong New Area of Shanghai, and to explore related influencing factors, so as to provide a reference for improving self-management of health among the elderly. MethodsConvenience sampling was used to conduct, a face-to-face questionnaire survey among participants who underwent the elderly health examination in Lingqiao Community in Pudong New Area of Shanghai from April to May 2025. A self-designed general demographic questionnaire was used to collect participants’ basic information and self-rated health status, and the Health-Promoting Behavior of Elderly People Scale was used to investigate health-promoting behaviors. The scale comprised 22 items across six dimensions, including health habits, social participation, health responsibility, healthy diet, physical exercise, and oral health care, with a total score of 88. A score ≥70.4 was defined as good health-promoting behaviors. StataMP 17.0 statistical software was used for data analyses. Chi-square tests and logistic regression models were applied to analyze the factors influencing health-promoting behaviors of residents. ResultsThe mean health-promoting behavior score among 1 077 participants was 69.00 (64.00, 75.00) [M(P25, P75)] points, with 44.20% individuals (476/1 077) exhibiting good health-promoting behaviors. Logistic regression analyses revealed that living in urban areas (OR=1.398, 95%CI: 1.035‒1.888), having a junior high school education (OR=1.447, 95%CI: 1.027‒2.039), having a high school education or higher (OR=2.622, 95%CI: 1.687‒4.074), having one chronic disease (OR=1.859, 95%CI: 1.344‒2.571), having two or more chronic diseases (OR=1.816, 95%CI: 1.278‒2.580), and self-rated health status better than that of most peers (OR=2.611, 95%CI: 1.691‒4.030) were positively associated with good health-promoting behaviors among older adults, whereas advanced age (≥80 years) was negatively associated with good health-promoting behaviors (OR=0.437, 95%CI: 0.257‒0.713). ConclusionThe health-promoting behaviors of elderly residents in the community were generally at a favorable level, while the social participation and health responsibility dimensions still need to be strengthened. Particular attention should be paid to elderly populations in rural areas, those with low educational attainment, those without self-reported chronic diseases, those with poor self-rated health and the advanced-aged elderly by implementing precise and personalized health education and behavioral guidance as well as actively conducting health promotion activities regarding age-appropriate exercise and dietary guidance.
2.Postoperative complications of ex vivo liver resection combined with autologous liver transplantation in treatment of advanced hepatic alveolar echinococcosis at high altitude and related prevention and treatment strategies
Qingshan TIAN ; Shaopei FENG ; Yamin GUO ; Xiumin HAN ; Shunyun ZHAO ; Chengjie YE ; Yongde AN ; Shile WU ; Xiangqian WANG ; Haibo ZHENG ; Wenjun ZHU ; Jide A ; Wei GAO ; Hongshuai PAN
Journal of Clinical Hepatology 2021;37(9):2153-2160
Objective To investigate the postoperative complications of ex vivo liver resection combined with autologous liver transplantation in the treatment of end-stage hepatic alveolar echinococcosis at high altitude and related prevention and treatment strategies. Methods Surgical data and follow-up data were collected from 11 patients with end-stage hepatic alveolar echinococcosis who underwent autologous liver transplantation in Qinghai People's Hospital from January 2013 to March 2019, and intraoperative and postoperative conditions were analyzed. Results All 11 patients underwent autologous liver transplantation successfully, without intraoperative death, among whom 2(18.18%) underwent hemi-extracorporeal hepatectomy and 9 (81.82%) underwent total extracorporeal hepatectomy. For the reconstruction of the retrohepatic inferior vena cava, 2 patients (18.18%) underwent reconstruction with the autologous great saphenous vein, 4 patients (36.36%) underwent reconstruction with artificial vessels, and the autologous retrohepatic inferior vena cava was preserved in 5 patients (45.45%). For biliary reconstruction, 8 patients (72.73%) underwent choledochoenterostomy and 3 (27.27%) underwent choledochocholedochostomy. The main postoperative complications of the 11 patients included bleeding in 2 patients (18.18%), bile leakage and abdominal infection in 4 patients (36.36%), bilioenteric anastomotic stenosis in 1 patient (9.09%), thrombus in 2 patients (18.18%), pulmonary infection and pleural effusion in 2 patients (18.18%), and echinococcosis recurrence in 1 patient (9.09%). Of all 11 patients, 2 (18.18%) died during the perioperative period, and the other 9 patients (81.82%) were improved and discharged. Conclusion Bleeding, biliary complications, and infection are the main causes of death in patients undergoing autologous liver transplantation at high altitude. An accurate understanding of surgical indication, careful multidisciplinary evaluation before surgery, superb operation during surgery, standardized surgical procedures, and fine perioperative management are the key to reducing perioperative mortality, avoiding and reducing postoperative complications, and achieving good long-term survival in patients undergoing autologous liver transplantation.
3.Present situation and progress of treatment of advanced hepatic alveolar echinococcosis
Shunyun ZHAO ; Jide A ; Shile WU ; Haihong ZHU ; Xiangqian WANG ; Wei GAO ; Yamin GUO
Chinese Journal of Hepatobiliary Surgery 2020;26(3):233-236
Hepatic alveolar echinococcosis is a zoonotic parasitic disease. The therapeutic options of advanced hepatic alveolar echinococcosis mainly include: operation combined with drug treatment, percutaneous transhepatic biliary drainage, focus puncture drainage, drug treatment, liver transplantation. The individualized and comprehensive treatment mainly based on surgery is an ideal treatment method for advanced hepatic alveolar echinococcosis. This paper summarized the related literature at home and abroad, combined with clinical practice, and summarized the current situation and progress of the treatment of advanced hepatic alveolar echinococcosis.
4.Short term efficacy and toxicity of apatinib and docetaxel combined with cisplatin chemotherapy for advanced gastric cancer
GAO Shile ; LU Donghui ; LIU Meiqin ; WANG Chong ; WEI Lei ; XU Peng ; LIU Yan ; TANG Zhengzhong ; HU Zongtao
Chinese Journal of Cancer Biotherapy 2018;25(11):1131-1134
Objective: : To observe the short-term efficacy and toxicity of apatinib monotherapy as well as docetaxel plus cisplatin in advanced gastric cancer. Method: : According to inclusion and exclusion criteria, 108 patients with advanced gastric cancer in the 105th Hospital of PLA were selected. According to random table grouping method, there were 54 cases in group A and 54 cases in group B. Patients in group A received continuous oral administration of apatinib alone, while group B received docetaxel plus cisplatin chemotherapy, with 3 weeks as a cycle and 4 cycles for a course. The efficacy and side effects were evaluated 3 months later. Results: : In groupA, there were 4 cases of CR, 25 cases of PR, 18 cases of SD and 7 cases of PD; the ORR was 53.7% and DCR was 87%. In group B, there were 2 cases of CR, 19 cases of PR, 21 cases of SD and 12 cases of PD; the ORR was 38.9% and DCR was 77.8%. The ORR and DCR in group A were significantly better than those in group B (P<0.05). The main adverse reactions were gastrointestinal reaction, myelosuppression, hypertension and hand-foot syndrome, all of which were grade 1 to 2; The incidence of bone marrow suppression and gastrointestinal reaction in group A was lower than that in group B (P<0.05), while the incidence of hand-foot syndrome and hypertension in group B was lower than that in group A (P<0.01). Conclusion: :The short-term efficacy of targeted therapy of apatinib alone was better than that of docetaxel combined with cisplatin chemotherapy, and the toxicity and side effects of both regimens were controllable;Apatinib can be used as the primary regimen for the treatment of advanced gastric cancer.
5.One case on esophageal cancer accompanied with eyeball and liver metastasis
Shile GAO ; Zongtao HU ; Liuyi DONG ; Chong WANG ; Donglai LV ; Chun ZHENG
Practical Oncology Journal 2015;(4):347-349
Esophageal cancer with eyeball metastasis is scarce,and the clinical diagnosis is based on ul-trasound.The treatment method is surgical removal at present.Our focus is through other local or systemic treat-ment to protect eyeball,protect the integrity intact and facial appearance.One patient's clinical data with esopha-geal eyeball metastasis from the People′s Liberation Army Cancer Center of No.105 Hospital was included.The patient was completed“enucleation of the right side of eyeball” by ultrasound diagnosis.The results of pathologi-cal suggested that poorly differentiated squamous cell carcinoma metastasis in the eye.Eyeball metastases′s opera-tion was received a good recovery after 2 months and there was no recurrence.In the present paper,we discuss e-sophageal eyeball metastases clinical characteristics and methods of diagnosis and treatment combined with the lit-erature.
6.Development of time-resolved immunofluorometric assays for Dickkopf-1 and application on sera of patients with lung cancer
Shile SHENG ; Qing WANG ; Wenxin QIN ; Bin YU ; Gang HUANG
Chinese Journal of Laboratory Medicine 2008;31(11):1259-1263
Objective To develop a highly sensitive and accurate time-resolved immunofluorometric assay (TR-IFMA) for measurement of Dickkopf-1(DKK-1),as a novel serologic biomarker for lung cancer. Methods The study constructed a two-manoclonal-antibody "sandwich"-type assay and the sensitivity, within run CV and between run CV and accuracy were evaluated. Serum DKK-1 concentrations were measured by TR-IFMA in 120 healthy controls, in 72 benign lung disease patients, and in 212 lung cancer patients before surgery. The association between serum DKK-1 levels and clinicopathological features were evaluated. Results A standard curve for DKK-1 TR-IFMA had been developed with good sensitivity (0.08 μg/L). Both within run CV and between run CV were less than 6.5%. Accuracy studies, parallelism and precision data were determined and all found to be satisfactory. The validity of DKK-1 assay was confirmed by the good correlation between the results obtained by TR-IFMA and commercial ELISA (r=0.972, P=0.01). The serum levels of DKK-1 were higher in lung cancer patients 31.93(79.47-18.03) μg/L than in benign lung diseases 15.25(18.41-11.49) μg/L and in healthy controls 13. 90( 16. 91-11.02) μg/L DKK-1 levels were significant associated with the presence of distant metastases, as well as lymph node metastases and TNM stage, but not with patients' age, gender and tumor histology. At the cutoff of 22.63 μg/L, the diagnostic sensitivity, specificity, accuracy, positive predictive value and negative predictive value of the TR-IFMA for lung carcinoma were 68.4%, 92.2%, 82.1% ,90.6% and 72.5%. Diagnostic sensitivity and accuracy were higher for small cell carcinoma than for non-small cell carcinoma (70.7% vs 69.5% and 85.6% vs 80.7%, respectively). Conclusions A highly sensitive and reliable TR-IFMA for DKK-1 has been developed. The determination of serum DKK-1 levels may be useful for diagnosis and tumor staging of lung cancer.

Result Analysis
Print
Save
E-mail